Navigation Links
Access Pharmaceuticals to Present Data on ProLindac(TM) at the AACR-NCI-EORTC 'Molecular Targets and Cancer Therapeutics' Conference
Date:10/18/2007

DALLAS, Oct. 18 /PRNewswire-FirstCall/ -- Access Pharmaceuticals, Inc. (OTC Bulletin Board: ACCP) announced today that its collaborators will be presenting clinical and preclinical data on its lead anticancer compound, ProLindac(TM), at the joint symposium of the American Association for Cancer Research (AACR), National Cancer Institute (NCI) and European Organization for Research and Treatment of Cancer (EORTC) entitled "International Conference Molecular Targets and Cancer Therapeutics: Discovery, Biology, and Clinical Applications" taking place October 22-26, 2007 at the Moscone Convention Center West in San Francisco, CA.

An update on Access' ongoing ProLindac Phase 2 clinical study will be presented during Poster Session A, "Clinical Trials" in Abstract #A145 entitled "AP5346, a pH-dependent polymer-vectorized DACH, is safe at pharmacodynamically active doses: Results from an ongoing phase II trial in borderline potentially platinum-sensitive ovarian cancer (OC) patients" on Tuesday, October 23, 2007 from 12:30 p.m. PDT.

New ProLindac preclinical data will appear in two posters presented during Poster Session C, Novel Drug Delivery Systems, on Thursday, October 25, 2007 from 12:30 p.m. PDT:

Abstract #C105 : "Molecular and cellular effects of AP5346, a novel DACH- platinum linked polymer-compound, compared to oxaliplatin and cisplatin in a panel of human cancer cell lines."

Abstract #C110: "Antiproliferative activity of AP5346, a novel DACH- platinum compound, alone and in combination with other cytotoxics, in human colon and ovarian cancer cells."

ProLindac is a novel DACH platinum prodrug which has been shown to be active in a wide variety of solid tumors in both preclinical models and in human trials. Access believes that ProLindac's unique molecular design potentially could eliminate some of the toxic side effects seen in the currently marketed DACH platinum, Eloxatin, which has sales in excess of $2 billion.

About
'/>"/>

SOURCE Access Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. PromegaExpress Expands Easy Access to Products with New Cabinet
2. Access and Somanta Announce Data to be Presented on Angiolix at ASCO Oncology Conference
3. Access Pharmaceuticals Announces Poster Presentations on ProLindac at the American Association for Cancer Research 2007 Annual Meeting
4. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
5. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
8. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
9. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
10. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
11. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... , Aug. 3, 2015  Depomed, Inc. (NASDAQ: ... Horizon Pharma plc,s (NASDAQ: HZNP ) ("Horizon") announcement ... Directors ("Depomed Board") set a record date to determine ... The Depomed Board will review the request ... received today and contains the information required under Depomed,s ...
(Date:8/3/2015)... NEW YORK , August 3, 2015 /PRNewswire/ ... report published by Persistence Market Research "Global Market ... to Witness Highest Growth by 2022", ... at US$15 Bn by the end of 2015 and ... 6.8% from 2015 to 2022, to account for ...
(Date:8/3/2015)... SPRINGS, Florida , August 3, 2015 ... development agreements between biotech companies, military surgical ... solutions & therapies with regards to severe ... positive clinical enhancements for regenerative medicine and ... recent developments, partnerships and advancements in focus ...
Breaking Medicine Technology:Depomed Comments on Horizon Pharma Announcement 2Depomed Comments on Horizon Pharma Announcement 3Depomed Comments on Horizon Pharma Announcement 4Depomed Comments on Horizon Pharma Announcement 5Depomed Comments on Horizon Pharma Announcement 6Global Physiotherapy Equipment Market Will Reach US$ 23.7 Billion by 2022: Persistence Market Research 2Global Physiotherapy Equipment Market Will Reach US$ 23.7 Billion by 2022: Persistence Market Research 3Global Physiotherapy Equipment Market Will Reach US$ 23.7 Billion by 2022: Persistence Market Research 4Biotech Advancements Coupled with Collaborative Partnerships Focus on Developing Orphan Drug Products & Treatments for Critical-Care Patients With Severe Wound Conditions 2Biotech Advancements Coupled with Collaborative Partnerships Focus on Developing Orphan Drug Products & Treatments for Critical-Care Patients With Severe Wound Conditions 3Biotech Advancements Coupled with Collaborative Partnerships Focus on Developing Orphan Drug Products & Treatments for Critical-Care Patients With Severe Wound Conditions 4Biotech Advancements Coupled with Collaborative Partnerships Focus on Developing Orphan Drug Products & Treatments for Critical-Care Patients With Severe Wound Conditions 5Biotech Advancements Coupled with Collaborative Partnerships Focus on Developing Orphan Drug Products & Treatments for Critical-Care Patients With Severe Wound Conditions 6
... JOSEPH, Mich., June 17 GeneGo, Inc., a ... biology, announced,today that they were awarded a Phase ... development of a platform for functional data analysis ... Cancer,Institute, Boston on the project. The system, MetaMiner ...
... 17 ,Oridion Systems Ltd. - (SWX: ORIDN) ... the clinical benefit of end-tidal,CO2 (EtCO2) monitoring ... medical congresses in the United States and ... in San Diego, California, Dr.,Vargo, of the ...
Cached Medicine Technology:GeneGo is Awarded NCI Grant for Development of Systems Biology Platform for Integrative Data Analysis in Cancer 2Oridion Announces Major Medical Research and Congress Presentations 2Oridion Announces Major Medical Research and Congress Presentations 3
(Date:8/3/2015)... ... August 03, 2015 , ... A recent survey ... number of Hispanics believe people can positively affect their diabetes, few look beyond ... said making diet changes was important. Far fewer participants mentioned the need for ...
(Date:8/3/2015)... ... August 03, 2015 , ... Novatus, Inc. today ... management solution, as well as announced the date of its next major release. ... of contract management tasks as well as enhancements to the customer experience. ...
(Date:8/3/2015)... ... August 03, 2015 , ... ... to Ahjumawi Lava Springs, California’s northernmost and among its least visited State Parks. ... water aquifers, whose main outflow is at Ahjumawi Lava Springs, part of the ...
(Date:8/3/2015)... ... August 03, 2015 , ... Illinois Health & Science (IHS) has completed ... The acquisition includes all of IBAM NA’s cyclotron sites and research and development facilities. ... regionally located business, as well as a large manufacturing hub in Noblesville, Indiana,” said ...
(Date:8/3/2015)... Spring, MD (PRWEB) , ... August 03, 2015 , ... ... the addition of a new associate podiatrist, creating the largest medical practice in the ... foot and ankle medicine. FASMA operates 21 locations with 33 doctors. , Dr. Hetal ...
Breaking Medicine News(10 mins):Health News:Hispanics More Likely to Struggle with Misinformation About Diabetes 2Health News:Hispanics More Likely to Struggle with Misinformation About Diabetes 3Health News:Hispanics More Likely to Struggle with Misinformation About Diabetes 4Health News:Novatus Unveils Milestone Software Release 2Health News:Medicine Lake Aquifer could ease California drought says fresh water advocate Sharon Kleyne – but is this necessary? 2Health News:Medicine Lake Aquifer could ease California drought says fresh water advocate Sharon Kleyne – but is this necessary? 3Health News:Medicine Lake Aquifer could ease California drought says fresh water advocate Sharon Kleyne – but is this necessary? 4Health News:Illinois Health & Science Expands Nuclear Medicine Footprint With Purchase of IBA Molecular North America, Inc. 2Health News:Leading Foot and Ankle Medical Practice Adds Three New Podiatrists 2Health News:Leading Foot and Ankle Medical Practice Adds Three New Podiatrists 3Health News:Leading Foot and Ankle Medical Practice Adds Three New Podiatrists 4
... BOSTON Ask anyone who suffers from migraine headaches what ... to hear "go into a dark room." And although ... reason why has been unclear. Now scientists at ... visual pathway that underlies sensitivity to light during migraine in ...
... information pathways converge in brain , SUNDAY, Jan. 10 ... exacerbates the already debilitating pain of migraines, even in ... 10 in Nature Neuroscience reveals how visual ... this phenomenon. , Although the findings are unlikely to ...
... ... treatment, Francisco Peinado got plundered by credit card debt and endless collection calls. However, a ... a casualty of medical bankruptcy, which based on a New York Times article, is growing. ... (PRWEB) January 10, ...
... ... Kadrich’s Leading Security Book Endpoint Security, , ... San Jose, CA (PRWEB) January 10, 2010 -- The Security ... announced its support for recently appointed White House cyber-security “czar” Howard Schmidt. A ...
... Mark5inc ... requires to know about attaining whiter and brighter teeth. , ... (PRWEB) January 2, 2010 -- We all were born ... boast our first set of teeth to the world, which were temporary. As we grew, ...
... interpersonal relationships stems weight gain, study finds ... psychotherapy program may work better than traditional health ... obesity from becoming excessively fatter, researchers report. ... by targeting the underlying social and interpersonal difficulties ...
Cached Medicine News:Health News:Study explains why light worsens migraine headaches 2Health News:Study explains why light worsens migraine headaches 3Health News:Why Light Hurts During Migraines 2Health News:Why Light Hurts During Migraines 3Health News:Cancer Patient's Medical Debt Ends in Brother's Credit Card Debt Settlement Victory Over Bankruptcy 2Health News:Cancer Patient's Medical Debt Ends in Brother's Credit Card Debt Settlement Victory Over Bankruptcy 3Health News:Cancer Patient's Medical Debt Ends in Brother's Credit Card Debt Settlement Victory Over Bankruptcy 4Health News:Cancer Patient's Medical Debt Ends in Brother's Credit Card Debt Settlement Victory Over Bankruptcy 5Health News:The Security Consortium Announces Support for White House Cyber Chief Schmidt 2Health News:The Security Consortium Announces Support for White House Cyber Chief Schmidt 3Health News:The Security Consortium Announces Support for White House Cyber Chief Schmidt 4Health News:Mark5inc Teeth Whitening Resource Is Presented To Web 2
With the Symphony family of Pacemakers, Ela presents the most advanced technology on the market. Symphony, lighter than a passport, will take your patients further, offering fast follow-up, using new...
... Measuring System delivers precise and accurate Measurements! ... receiving a better examination when they see ... equipment. ,User Friendly - after only 5 ... can become very proficient in the operation ...
Gentle curve facilitates less traumatic removal from eye. Increased length ideal for myopic eyes...
Curved Cannula for probing and irrigating lacrimal duct. 0.80mm (21 G)...
Medicine Products: